Björkman Anders, Svensson Peter J, Hillarp Andreas, Burtscher Isabella M, Rünow Anders, Benoni Göran
Department of Orthopaedics, University Hospital Malmö, S-205 02 Malmö, Sweden.
Clin Orthop Relat Res. 2004 Aug(425):168-72.
The purpose of the current study was to determine whether factor V Leiden and the prothrombin 20210A gene mutation are risk factors for osteonecrosis of the femoral head in different etiologic groups of osteonecrosis in adults and whether patients with idiopathic osteonecrosis of the femoral head have a higher frequency of thromboembolic events compared with the general population. We investigated 63 adult patients with nontraumatic osteonecrosis of the femoral head for etiologic factors, such as corticosteroid medication and alcohol abuse, and the occurrence of factor V Leiden and the prothrombin 20210A gene mutation. In 35 patients, the disease was considered idiopathic and 10 of these patients (29%) had factor V Leiden or the prothrombin 20210A gene mutation or both. Mutations in factor V or the prothrombin 20210A gene were significantly more frequent in patients with idiopathic osteonecrosis than in a population of healthy control subjects (odds ratio, 2.7; 95% confidence interval range, 1.2-5.8) and in patients with osteonecrosis caused by corticosteroid medication or alcohol abuse (odds ratio, 10.8; 95% confidence interval range, 1.4-84). 36% of patients with a gene mutation had had a thromboembolic event compared with 8% of patients without a gene mutation. Thromboembolic events were more common among patients with idiopathic osteonecrosis (17%) compared with the general population (4%) and with patients with osteonecrosis caused by corticosteroid medication or alcohol abuse (7%).
本研究的目的是确定成人不同病因组股骨头坏死中,凝血因子V莱顿突变和凝血酶原20210A基因突变是否为股骨头坏死的危险因素,以及特发性股骨头坏死患者与普通人群相比,血栓栓塞事件的发生率是否更高。我们调查了63例非创伤性股骨头坏死的成年患者,了解其病因,如皮质类固醇药物使用和酗酒情况,以及凝血因子V莱顿突变和凝血酶原20210A基因突变的发生情况。35例患者被认为是特发性的,其中10例(29%)有凝血因子V莱顿突变或凝血酶原20210A基因突变,或两者皆有。特发性股骨头坏死患者中,凝血因子V或凝血酶原20210A基因突变的频率显著高于健康对照人群(优势比为2.7;95%置信区间为1.2 - 5.8),也高于因皮质类固醇药物或酗酒导致股骨头坏死的患者(优势比为10.8;95%置信区间为1.4 - 84)。有基因突变的患者中36%曾发生过血栓栓塞事件,而无基因突变的患者中这一比例为8%。与普通人群(4%)以及因皮质类固醇药物或酗酒导致股骨头坏死的患者(7%)相比,特发性股骨头坏死患者中血栓栓塞事件更为常见(17%)。